RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research. The company (publ) was incorporated in 1988 and is headquartered in Stockholm, Sweden.
Metrics to compare | RAYb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRAYbPeersSector | |
---|---|---|---|---|
P/E Ratio | 39.4x | 18.6x | −0.6x | |
PEG Ratio | 0.23 | 0.08 | 0.00 | |
Price/Book | 8.5x | 2.8x | 2.6x | |
Price / LTM Sales | 5.9x | 1.4x | 3.2x | |
Upside (Analyst Target) | 28.1% | 19.4% | 45.4% | |
Fair Value Upside | Unlock | 24.8% | 7.7% | Unlock |